LAT4 drives temozolomide induced radiotherapy resistance in glioblastoma by enhancing mTOR pathway activation.
Zang W, Liu Y, Zheng J, Huang Y, Chen L, Li C, Zhao J, Zhou Q, Xu Y, Wang Z, Cao Y, Zhang W, Li J, Lu Y.
Zang W, et al. Among authors: li c, li j.
Cancer Cell Int. 2024 Dec 18;24(1):407. doi: 10.1186/s12935-024-03590-0.
Cancer Cell Int. 2024.
PMID: 39696435
Free PMC article.